CCND1 and sarcoma: It may be postulated that cyclin D1 overexpression can be one of the events associated with the transformation of the benign duct to dysplasia or progression of dysplasia to adenocarcinoma, and p16 overexpression may be related to the progression to high-grade sarcoma.